Allogene Therapeutics: Q1 Earnings Snapshot

Published: 2026-05-13 16:09:08 ET ALLO

Published on 05/13/2026 at 04:09 pm EDT

SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Allogene Therapeutics Inc. (ALLO) on Wednesday reported a loss of $42.6 million in its first quarter.

The South San Francisco, California-based company said it had a loss of 18 cents per share.

The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 19 cents per share.

In the final minutes of trading on Wednesday, the company's shares hit $2.33. A year ago, they were trading at $1.13.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ALLO at https://www.zacks.com/ap/ALLO

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News